StockData
Edwards Lifesciences Corp logo

Edwards Lifesciences Corp

EWNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3060% above fair value
$103.88−1.35 (-1.28%)

Close on Nov 19, 2026Market cap $59.88BP/E 59.7Yield –

Edwards Lifesciences Accrued Customer Rebates, Product Returns and Sales by Quarter

Accrued Customer Rebates, Product Returns and Sales Allowances ($M)

Edwards Lifesciences Accrued Customer Rebates, Product Returns and Sales: $185M in Q3 2026, up 16.8% from a year earlier. That is the highest of the 32 quarters on record here.

Latest, Q3 2026
185
Period ended Sep 30, 2026
Change on a year earlier
+16.8%
158 in Q3 2025
History
32 quarters
Since Q4 2017
Sources
31
Documents cited below

Where the Q3 2026 figure comes from

Source: SEC Filing (0001099800-26-000054) ↗

Reported in Form 10-K / Form 10-Q Other Accrued Liabilities Footnote.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAccrued Customer Rebates, Product Returns and Sales Allowances ($M)Year on yearSource
Q3 2026Sep 30, 2026185+16.8%SEC Filing (0001099800-26-000054) ↗
Q2 2026Jun 30, 2026164+14.2%SEC Filing (0001099800-26-000043) ↗
Q1 2026Mar 31, 2026144+21.4%SEC Filing (0001099800-26-000026) ↗
Q4 2025Dec 31, 2025157+12.4%SEC Filing (0001099800-26-000054) ↗
Q3 2025Sep 30, 2025158+13.0%SEC Filing (0001099800-25-000062) ↗
Q2 2025Jun 30, 2025143+18.7%SEC Filing (0001099800-25-000048) ↗
Q1 2025Mar 31, 2025119-1.4%SEC Filing (0001099800-25-000023) ↗
Q4 2024Dec 31, 2024139+12.8%SEC Filing (0001099800-26-000009) ↗
Q3 2024Sep 30, 2024140+0.4%SEC Filing (0001099800-24-000086) ↗
Q2 2024Jun 30, 2024121-7.3%SEC Filing (0001099800-24-000078) ↗
Q1 2024Mar 31, 2024121+7.4%SEC Filing (0001099800-24-000039) ↗
Q4 2023Dec 31, 2023124+6.4%SEC Filing (0001099800-25-000005) ↗
Q3 2023Sep 30, 2023140+52.0%SEC Filing (0001099800-23-000039) ↗
Q2 2023Jun 30, 2023130+45.2%SEC Filing (0001099800-23-000034) ↗
Q1 2023Mar 31, 2023112+43.2%SEC Filing (0001099800-23-000021) ↗
Q4 2022Dec 31, 2022116+50.8%SEC Filing (0001099800-24-000004) ↗

Cite this data

StockData. (2026). Edwards Lifesciences Accrued Customer Rebates, Product Returns and Sales ($M), quarterly Q4 2017–Q3 2026 [Data set]. Compiled from Edwards Lifesciences SEC filings and investor materials. https://stockdatahq.com/stocks/ew/kpis/res-rebates

See every metric in the Edwards Lifesciences KPI table. Data updated Nov 7, 2026.

See a number that looks wrong?